New analysis of a 2015 study shows a link between intensive BP control and risk for new LV conduction disease, suggesting the conduction system could be seen as something we should protect.
About one in five patients with long COVID-19, regardless of whether they had been hospitalized, can show cardiac impairment by MRI at 6 months; the impairment often persists at 1 year.
But regression of myocardial fibrosis wasn t tied to the small LVEF improvement observed in the PIROUETTE trial of pirfenidone in patients with heart failure with preserved ejection fraction.